ReCLAIM-2: Phase 2 Trial of Subcutaneous Elamipretide in Patients with Noncentral Geographic Atrophy

Time: 12:30 pm
day: Day Two


  • Elamipretide is a first in class mitochondrial restorative compound
  • Review results of phase 2 trial demonstrating positive secondary endpoints and possible path to phase 3 enrichment
  • Cover ellipsoid zone endpoint and how it relates to mitochondrial health